RU2426738C2 - Очистка белков с помощью катионного поверхностно-активного вещества - Google Patents

Очистка белков с помощью катионного поверхностно-активного вещества Download PDF

Info

Publication number
RU2426738C2
RU2426738C2 RU2007141623/10A RU2007141623A RU2426738C2 RU 2426738 C2 RU2426738 C2 RU 2426738C2 RU 2007141623/10 A RU2007141623/10 A RU 2007141623/10A RU 2007141623 A RU2007141623 A RU 2007141623A RU 2426738 C2 RU2426738 C2 RU 2426738C2
Authority
RU
Russia
Prior art keywords
protein
target protein
proteins
solution
uricase
Prior art date
Application number
RU2007141623/10A
Other languages
English (en)
Russian (ru)
Other versions
RU2007141623A (ru
Inventor
Меир ФИШЕР (IL)
Меир ФИШЕР
Элияху ХАРОШ (IL)
Элияху ХАРОШ
Original Assignee
Савиент Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Савиент Фармасьютикалз, Инк. filed Critical Савиент Фармасьютикалз, Инк.
Publication of RU2007141623A publication Critical patent/RU2007141623A/ru
Application granted granted Critical
Publication of RU2426738C2 publication Critical patent/RU2426738C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
    • C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C12N9/0048—Uricase (1.7.3.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y107/00—Oxidoreductases acting on other nitrogenous compounds as donors (1.7)
    • C12Y107/03—Oxidoreductases acting on other nitrogenous compounds as donors (1.7) with oxygen as acceptor (1.7.3)
    • C12Y107/03003—Factor-independent urate hydroxylase (1.7.3.3), i.e. uricase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
RU2007141623/10A 2005-04-11 2006-04-12 Очистка белков с помощью катионного поверхностно-активного вещества RU2426738C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67052005P 2005-04-11 2005-04-11
US60/670,520 2005-04-11

Publications (2)

Publication Number Publication Date
RU2007141623A RU2007141623A (ru) 2009-08-10
RU2426738C2 true RU2426738C2 (ru) 2011-08-20

Family

ID=36873313

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2007141623/10A RU2426738C2 (ru) 2005-04-11 2006-04-12 Очистка белков с помощью катионного поверхностно-активного вещества

Country Status (9)

Country Link
US (2) US20220073886A1 (cs)
AU (1) AU2006339865B2 (cs)
BR (1) BRPI0612943A2 (cs)
CA (1) CA2611249C (cs)
CZ (1) CZ305852B6 (cs)
NZ (1) NZ562293A (cs)
RU (1) RU2426738C2 (cs)
TW (1) TWI418564B (cs)
ZA (1) ZA200708652B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107475221A (zh) * 2017-09-19 2017-12-15 青岛农业大学 一种新型溶菌酶制剂及其制备方法
CN109430514B (zh) * 2018-11-02 2022-07-26 广东海洋大学 一种制备罗非鱼-豆粕共沉淀蛋白的方法
WO2020160322A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Tolerization reduces intolerance to pegloticase and prolongs the urate lowering effect (triple)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485176A (en) * 1982-06-28 1984-11-27 E. I. Du Pont De Nemours & Company Turbidimetric method for measuring protein in urine and cerebrospinal fluid
RU2105812C1 (ru) * 1989-07-13 1998-02-27 Санофи Полипептид, обладающий уратоксидазной активностью, фрагмент днк, обеспечивающий экспрессию полипептида с уратоксидазной активностью (варианты), вектор экспрессии, содержащий фрагмент днк, обеспечивающий экспрессию полипептида с уратоксидазной активностью (варианты), штамм, экспрессирующий полипептид, обладающий уратоксидазной активностью (варианты), способ получения полипептида, обладающего уратоксидазной активностью

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3451996A (en) * 1968-02-12 1969-06-24 Thompson Farms Co Method for the preparation of heparin
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
JPH01216939A (ja) * 1988-02-24 1989-08-30 Hoechst Japan Kk 末熟児頭蓋内出血阻止剤
US6783965B1 (en) * 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
WO2004092393A1 (en) * 2003-01-09 2004-10-28 Genentech, Inc. Purification of polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485176A (en) * 1982-06-28 1984-11-27 E. I. Du Pont De Nemours & Company Turbidimetric method for measuring protein in urine and cerebrospinal fluid
RU2105812C1 (ru) * 1989-07-13 1998-02-27 Санофи Полипептид, обладающий уратоксидазной активностью, фрагмент днк, обеспечивающий экспрессию полипептида с уратоксидазной активностью (варианты), вектор экспрессии, содержащий фрагмент днк, обеспечивающий экспрессию полипептида с уратоксидазной активностью (варианты), штамм, экспрессирующий полипептид, обладающий уратоксидазной активностью (варианты), способ получения полипептида, обладающего уратоксидазной активностью

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ZHANG W. ET AL. Forward and backward extraction of BSA using mixed reverse micellar system of СТАВ and alkyl halides. // J. Biochemical Engineering, 2002, v.2, n.1, pp.1-5. ZHANG T. ET AL. Affinity extraction of BSA with reversed micellar system composed of unbound Cibacron Blue. // Biotechnol. Prog., 1999, v.15, n.6, pp.1078-82. *

Also Published As

Publication number Publication date
AU2006339865B2 (en) 2012-01-12
CA2611249C (en) 2014-10-14
US20240026312A1 (en) 2024-01-25
RU2007141623A (ru) 2009-08-10
TW200722435A (en) 2007-06-16
CA2611249A1 (en) 2006-10-11
CZ305852B6 (cs) 2016-04-13
AU2006339865A1 (en) 2007-11-08
TWI418564B (zh) 2013-12-11
US20220073886A1 (en) 2022-03-10
AU2006339865A8 (en) 2008-08-07
NZ562293A (en) 2011-06-30
ZA200708652B (en) 2010-03-31
BRPI0612943A2 (pt) 2012-10-09
CZ2007701A3 (cs) 2008-04-16

Similar Documents

Publication Publication Date Title
US20200056160A1 (en) Purification of proteins with cationic surfactant
US20240026312A1 (en) Purification of proteins with cationic surfactant
US4828990A (en) Method for purifying an interferon
CN1972961A (zh) 血浆或者血清蛋白的分离
JP2020502104A (ja) ゲノム的に再コードした生物におけるセレノ−生物製剤の製造
CN108026165A (zh) 用于抗体碎片的改进的复性方法
EP1444249B1 (en) Method of protein purification
KR102286260B1 (ko) 설파타아제 단백질을 정제하는 방법
HK1126794B (en) Purification of proteins with cationic surfactant
MX2007012549A (en) Purification of proteins with cationic surfactant
CN113402592B (zh) 一种使用imac层析纯化非标签化crm197蛋白的方法
JPH0724596B2 (ja) インタ−フェロンの精製方法
Toorchen et al. Enzyme-inhibitor interactions as a basis for heterogeneity of extracellular cyclic AMP phosphodiesterases in Dictyostelium discoideum
WO2002004512A2 (en) Purification of human troponin i

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20141209

MM4A The patent is invalid due to non-payment of fees

Effective date: 20190413